R esistance arteries possess an intrinsic ability to constrict in response to increased intraluminal pressure, the "myogenic response." 1 The ability of resistance vessels to modulate their diameter in response to changes in intraluminal pressure is thought to be an important component of blood flow autoregulation, such that constant blood flow and tissue perfusion are maintained in the face of variations in blood pressure. 2,3 Specifically, intraluminal pressure results in a graded smooth muscle cell (SMC) depolarization from about Ϫ65 mV to about Ϫ40 mV, 4 likely because of activation of nonselective cation channels. 5 This depolarization activates L-type voltagedependent calcium (Ca 2ϩ ) channels, leading to elevation of the SMC cytosolic Ca 2ϩ concentration, SMC contraction, and vasoconstriction. 6 In the absence of negative feedback mechanisms to oppose myogenic constriction, resistance arteries would likely exhibit unstable membrane potentials and fluctuations in vascular diameter as a result of Ca 2ϩ dependent action potentials. 7 However, in vivo, graded and sustained changes in vascular diameter occur, such that blood flow is maintained despite changes in pressure. 1 Activation of hyperpolarizing potassium (K ϩ ) conductances, which oppose depolarization and vasoconstriction, are critical negative feedback mechanisms responsible for controlling the extent of myogenic constriction. 2,3,8 -10 Smooth muscle cells express two types of K ϩ channels which are primarily responsible for opposing myogenic depolarization:
R esistance arteries possess an intrinsic ability to constrict in response to increased intraluminal pressure, the "myogenic response." 1 The ability of resistance vessels to modulate their diameter in response to changes in intraluminal pressure is thought to be an important component of blood flow autoregulation, such that constant blood flow and tissue perfusion are maintained in the face of variations in blood pressure. 2, 3 Specifically, intraluminal pressure results in a graded smooth muscle cell (SMC) depolarization from about Ϫ65 mV to about Ϫ40 mV, 4 likely because of activation of nonselective cation channels. 5 This depolarization activates L-type voltagedependent calcium (Ca 2ϩ ) channels, leading to elevation of the SMC cytosolic Ca 2ϩ concentration, SMC contraction, and vasoconstriction. 6 In the absence of negative feedback mechanisms to oppose myogenic constriction, resistance arteries would likely exhibit unstable membrane potentials and fluctuations in vascular diameter as a result of Ca 2ϩ dependent action potentials. 7 However, in vivo, graded and sustained changes in vascular diameter occur, such that blood flow is maintained despite changes in pressure. 1 Activation of hyperpolarizing potassium (K ϩ ) conductances, which oppose depolarization and vasoconstriction, are critical negative feedback mechanisms responsible for controlling the extent of myogenic constriction. 2,3,8 -10 Smooth muscle cells express two types of K ϩ channels which are primarily responsible for opposing myogenic depolarization: (1) the large conductance Ca 2ϩ sensitive K ϩ (BK) channel, which is activated by both membrane depolarization and intracellular Ca 2ϩ , 8, 11 and (2) voltage-gated K ϩ channels (K V channels), which are steeply activated by membrane potential (V m ) depolarization. 9, 10, 12, 13 Interestingly, BK channels appear to be under the control of spatially-localized micromolar increases in Ca 2ϩ mediated by transient Ca 2ϩ release events from ryanodine receptors (Ca 2ϩ sparks). 3, 11, 14 Through BK channels, Ca 2ϩ sparks regulate V m , vascular tone, and blood pressure. 11,15 K V channels act in concert with BK channels to regulate SMC V m and vascular diameter and thus also play a significant role in regulating vascular tone. Inhibition of K V channels, for example with the classical inhibitors tetraethylammonium ions (TEA, Ն1 mmol/L) or 4-aminopyridine (4-AP), leads to a dramatic SMC depolarization (Ϸ20 mV) and vasoconstriction (Ϸ30%). 4, 9, 10, 13 Furthermore, K V channel inhibition leads to increased myogenic tone at a given pressure, 4, 9, 10 suggesting that under physiological conditions, K V channels serve to oppose myogenic constriction. The challenge, addressed by Chen et al 16 in this issue of Circulation Research, is to identify the molecular nature of the K V channel that has the unique properties to modulate the myogenic response.
The K V channel family comprises 12 subfamilies of related genes (K V 1 to 12) that form the ␣ pore-forming subunits. 17, 18 Although the expression of different K V ␤ subunits can serve to modulate channel activity, 18, 19 K V ␣ subunits with distinct biophysical characteristics can assemble as heterotetramers, enabling the formation of a diverse array of functional channels that operate within the physiologically relevant conditions of a particular cellular system. 9,10,20 Furthermore, the expression profile of K V channels may be tuned to satisfy the needs of a given system. For example, Plane et al 9 have shown that the relative expression of message for K V 1 subunits is significantly greater in 1 st and 2 nd order rat mesenteric arteries compared with 4 th order arteries.
Biophysical measurements and pharmacological inhibitors with varying specificities have traditionally been used to probe K V channel function in vascular SMCs. 3, 7, 20, 21 TEA and 4-AP are relatively nonselective inhibitors of K V channels, with TEA also inhibiting BK channels. 3 Correolide is often used to probe the contribution of K V 1 channels to the generation of functional K V current, although it can also bind to K V 2 subunits, albeit with much lower affinity than K V 1 subunits. 21 Given that heterotetrameric channels are expressed in vascular SMCs, and K V channels exhibit significant similarities in their activation and inactivation characteristics, conductance, and pharmacological sensitivities, it is difficult to conclusively gauge the relative contributions of each subtype to the functional K V current using traditional methods.
To overcome these issues, Chen et al 16 used a dominantnegative cDNA construct to suppress K V 1 currents in rat middle cerebral artery, and provide elegant molecular evidence for the involvement of K V 1 containing channels in the regulation of vascular function. Specifically, a mutant K V 1.5 construct (K V 1.5DN) containing a single tryptophan to phenylalanine substitution in the pore-forming region was transfected into reverse permeabilized cerebral arteries, under the assumption that the mutant subunits would coassemble with endogenous K V 1 subunits to form nonfunctional K V 1 channels independent of subunit composition or stoichiometry. This dominant negative construct has previously been shown to prevent K ϩ permeation through the channel without altering channel expression. 22 Importantly, Chen et al 16 verified that this construct specifically suppressed K V 1 but not K V 2 currents in a heterologous expression system, and that it did not affect the levels of other known components of the myogenic response. Myogenic constriction was enhanced in cerebral arteries overexpressing K V 1.5DN and decreased in arteries overexpressing wild-type K V 1.5 without affecting passive response characteristics in the absence of extracellular Ca 2ϩ over a range of intraluminal pressures. This effect of the dominant-negative channel on myogenic tone appears attributable to an exaggerated depolarization of the SMC V m evoked by intraluminal pressure, as would be expected in the presence of crippled K V channel function. Specifically, SMCs in K V 1.5DN transfected arteries were more depolarized than SMCs in mock transfected arteries pressurized to 80 mm Hg, whereas SMCs in arteries transfected with wild-type K V 1.5 were more hyperpolarized at identical pressure. In addition, correolide treatment had divergent effects on myogenic constriction of arteries transfected with K V 1.5DN versus arteries overexpressing wild-type K V 1.5, consistent with the assertion that K V 1.5DN serves to suppress the function of K V 1 containing channels that are involved in the myogenic response. These findings provide important insights into the composition of the molecular machinery responsible for modulating the level of myogenic depolarization in the vasculature and demonstrate the utility of a molecular-based approach to manipulate cellular components that underlie normal vascular function.
The molecular coding of K V channels is central to the proper function of different types of smooth muscle. For example, urinary bladder smooth muscle exhibits rapid action potentials and prolonged afterhyperpolarizations, and K V 2 family members, based on their kinetic properties, are key to this function. 23 However, in vascular smooth muscle, which do not typically fire action potentials and depend on graded changes in V m , K V 1 channels have a dominant role in opposing excitability. 9, 10, 13, 16 Thus, disabling K V 1 channel function would render vascular smooth muscle virtually defenseless to the depolarizing and vasoconstricting forces of intraluminal pressure and vasoconstricting agonists. Based on the current study and previous investigations of the role of K V channels in the vasculature, it is clear that K V 1 channels underlie the regulation of vascular smooth muscle V m over a wide range of physiologically relevant potentials (Ϫ65 to Ϫ40 mV) and constitute a critical negative feedback mechanism for regulating the extent of myogenic constriction. This body of work provides strong impetus to explore the involvement of endogenous modulators of K V 1 channel activity in the regulation of vascular function as well as the potential role of K V 1 channel dysfunction in pathological conditions such as hypertension and vasospasm. 24 
